Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip L Johnson

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
The International Journal of Neuropsychopharmacology|November 20, 2010
A selective, non-peptide CRF receptor 1 antagonist prevents sodium lactate-induced acute panic-like responsesAnantha Shekhar, Philip L Johnson, Stephanie D Fitz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 22, 2010
Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdalaMatthew W Hale, Philip L Johnson, Alex M Westerman, et al.
Current Drug Abuse Reviews|July 28, 2009
From QTL to candidate gene: a genetic approach to alcoholism researchJohn P Spence, Tiebing Liang, Lixiang Liu, et al.
Depression and Anxiety|April 19, 2012
Elevated tph2 mRNA expression in a rat model of chronic anxietyNina C Donner, Philip L Johnson, Stephanie D Fitz, et al.
Investigative Ophthalmology & Visual Science|October 4, 2012
Dorsomedial/Perifornical hypothalamic stimulation increases intraocular pressure, intracranial pressure, and the translaminar pressure gradientBrian C Samuels, Nathan M Hammes, Philip L Johnson, et al.
Journal of Psychopharmacology (Oxford, England)|August 24, 2012
Group II metabotropic glutamate receptor type 2 allosteric potentiators prevent sodium lactate-induced panic-like response in panic-vulnerable ratsPhilip L Johnson, Stephanie D Fitz, Eric A Engleman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 29, 2012
Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardiaPhilip L Johnson, Brian C Samuels, Stephanie D Fitz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 5, 2010
Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorderAndre I Molosh, Philip L Johnson, Stephanie D Fitz, et al.
Frontiers in Behavioral Neuroscience|April 17, 2023
Prior stress and vasopressin promote corticotropin-releasing factor inhibition of serotonin release in the central nucleus of the amygdalaPatrick J Ronan, Wayne J Korzan, Philip L Johnson, et al.
Brain Research|July 23, 2002
GABAergic drugs alter hypothalamic serotonin release and lordosis in estrogen-primed ratsCynthia S Hoffman, Todd M Westin, Holly M Miner, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
The International Journal of Neuropsychopharmacology|November 20, 2010
A selective, non-peptide CRF receptor 1 antagonist prevents sodium lactate-induced acute panic-like responsesAnantha Shekhar, Philip L Johnson, Stephanie D Fitz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 22, 2010
Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdalaMatthew W Hale, Philip L Johnson, Alex M Westerman, et al.
Current Drug Abuse Reviews|July 28, 2009
From QTL to candidate gene: a genetic approach to alcoholism researchJohn P Spence, Tiebing Liang, Lixiang Liu, et al.
Depression and Anxiety|April 19, 2012
Elevated tph2 mRNA expression in a rat model of chronic anxietyNina C Donner, Philip L Johnson, Stephanie D Fitz, et al.
Investigative Ophthalmology & Visual Science|October 4, 2012
Dorsomedial/Perifornical hypothalamic stimulation increases intraocular pressure, intracranial pressure, and the translaminar pressure gradientBrian C Samuels, Nathan M Hammes, Philip L Johnson, et al.
Journal of Psychopharmacology (Oxford, England)|August 24, 2012
Group II metabotropic glutamate receptor type 2 allosteric potentiators prevent sodium lactate-induced panic-like response in panic-vulnerable ratsPhilip L Johnson, Stephanie D Fitz, Eric A Engleman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 29, 2012
Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardiaPhilip L Johnson, Brian C Samuels, Stephanie D Fitz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 5, 2010
Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorderAndre I Molosh, Philip L Johnson, Stephanie D Fitz, et al.
Frontiers in Behavioral Neuroscience|April 17, 2023
Prior stress and vasopressin promote corticotropin-releasing factor inhibition of serotonin release in the central nucleus of the amygdalaPatrick J Ronan, Wayne J Korzan, Philip L Johnson, et al.
Brain Research|July 23, 2002
GABAergic drugs alter hypothalamic serotonin release and lordosis in estrogen-primed ratsCynthia S Hoffman, Todd M Westin, Holly M Miner, et al.
Pageof 7